GlassScriptPhysician profile
Ishraq K Kabir
NPI 1881056331
$13,797.43
in general payments reported to CMS, 2019-2025
25 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $114 · 2023: $629 · 2024: $13K · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Travel and Lodging: $1,145 · Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $11,500.00 |
| Travel and Lodging | $1,144.89 |
| Food and Beverage | $1,038.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,620.18 | 2024 | |
| Acumed LLC | $248.42 | 2023 | Biobridge, Ribloc |
| Janssen Pharmaceuticals, INC | $116.02 | 2023-2025 | Spravato, Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $85.56 | 2022-2023 | |
| Medtronic, INC. | $79.18 | 2023 | Sonicision, Ligasure, Progrip |
| Lifenet Health | $74.81 | 2023-2025 | Theragenesis Wound Matrix |
| Abbvie INC. | $71.73 | 2024-2025 | |
| Novo Nordisk INC | $67.84 | 2022-2024 | Wegovy |
| Kerecis Limited | $62.26 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.46 | 2024-2025 | Xifaxan |
| Abbott Laboratories | $46.73 | 2022-2024 | Proclaim |
| Exact Sciences Corporation | $35.74 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $33.04 | 2025 | Kisunla, Amyvid |
| Biohaven Pharmaceutical Holding Company LTD. | $25.40 | 2022 | |
| Teleflex LLC | $22.79 | 2023 | Quikclot |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $18.75 | 2025 | Irrisept |
| Avanos Medical | $17.82 | 2023 | On-Q* Pump and Accessories |
| Bioventus LLC | $17.08 | 2022 | |
| Esperion Therapeutics, INC. | $16.90 | 2025 | Nexletol |
| Davol INC. | $16.70 | 2024 | Phasix Mesh |
| Boston Scientific Corporation | $15.91 | 2023 | Watchman Flx |
| Merck Sharp & Dohme LLC | $14.74 | 2023 | Dificid |
| Idorsia Pharmaceuticals US INC | $14.29 | 2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $13.78 | 2025 | Farxiga |
| Kowa Pharmaceuticals America, INC. | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ishraq Kabir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.